Stock search

Ticker or company name

Illumina, Inc.

ILMN · NASDAQ · Life Sciences Tools & Services

$198,00Down −9,01 (−4,35%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$30,1 bn
Div. yield
—
Year to date
+57,8%
52 weeks: $112,65$309,35

Ratio score

75/100
Ratio would consider buying

based on 8 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

5 ✓ · 2 — · 1 ✕ · 2 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM33,654,037,9
Forward P/E39,1—29,5
PEG3,4—3,7
P/S6,64,96,6
EV/EBITDA26,344,329,9
P/FCF28,5—38,7
P/B9,65,55,4

Industry median — across 11 profitable companies in “Life Sciences Tools & Services” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 28 analysts

Buy
15
Hold
10
Sell
3

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20261,381,44Up +4,1%
Q2 20261,251,31Up +4,7%
Q1 20261,081,15Up +6,9%
Q4 20251,251,35Up +7,6%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue1,13 bn1,16 bn1,09 bn1,16 bn1,08 bn1,06 bn1,04 bn1,10 bn1,08 bn1,11 bn1,08 bn1,12 bn
EPS1,431,350,872,160,981,490,821,174,42−12,48−0,79−1,11
Margin19,5%17,9%12,3%28,8%13,8%22,2%12,6%16,8%65,3%−178,8%−11,7%−15,7%
FCF379 m161 m251 m266 m253 m204 m208 m335 m284 m49,0 m41,0 m173 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $23 562 (1 person), sales $721 m.

NameAmountSharesPrice
meister keith a.11 Nov 2026 · sale$407 4691 843$221,09
meister keith a.11 Nov 2026 · sale$1,02 m4 618$220,45
meister keith a.11 Nov 2026 · sale$2,70 m12 305$219,55
meister keith a.11 Nov 2026 · sale$5,04 m23 064$218,50
meister keith a.11 Nov 2026 · sale$1,87 m8 613$217,65
meister keith a.11 Nov 2026 · sale$1,11 m5 122$216,64
meister keith a.11 Nov 2026 · sale$5,81 m26 950$215,48
meister keith a.11 Nov 2026 · sale$236 0641 103$214,02
meister keith a.11 Nov 2026 · sale$3,24 m15 215$212,97
ericksen scott d10 Nov 2026 · sale$58 142267$217,76
meister keith a.10 Nov 2026 · sale$14 09064$220,16
meister keith a.10 Nov 2026 · sale$1,54 m7 015$219,94
meister keith a.10 Nov 2026 · sale$254 6911 177$216,39
meister keith a.10 Nov 2026 · sale$4,29 m19 914$215,66
meister keith a.10 Nov 2026 · sale$4,44 m20 693$214,77

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Life Sciences Tools & Services
Exchange
NASDAQ
Country
US
IPO date
28 Jun 2000

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
WSTWest Pharmaceutical Services$417,8083would consider45,5+12,6%18,8%
MTDMettler Toledo$1 727,2663would watch36,5+6,5%22,2%
IQVIQVIA$264,7372would consider31,3+8,8%8,1%
WATWaters Corporation$453,4229would not consider269,0—1,8%
AAgilent Technologies$172,9278would consider34,1+8,6%19,5%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.